This instrument is the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2021.

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. The whole of this instrument	1 July 2021.	1 July 2021

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority

This instrument is made under the National Health Act 1953.

4 Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2009

1 Subregulation 1A.1(2)

Omit “$180,960”, substitute “$181,500”.

2 Subregulation 1A.2(3)

Omit “$103,270”, substitute “$103,560”.

3 Regulation 1A.7 (table item 1)

Omit “15,580”, substitute “15,700”.

4 Regulation 1A.7 (table item 2)

Omit “21,180”, substitute “21,350”.

5 Subregulation 2.2(1) (table item 1, column 2)

Omit “223,340”, substitute “225,120”.

6 Subregulation 2.2(1) (table item 2, column 2)

Omit “168,700”, substitute “170,050”.

7 Subregulation 2.2(1) (table item 3, column 2)

Omit “43,020”, substitute “43,360”.

8 Subregulation 2.2(1) (table item 4, column 2)

Omit “33,710”, substitute “33,980”.

9 Subregulation 2.2(1) (table item 5, column 2)

Omit “12,730”, substitute “12,270”.

10 Subregulation 2.2(1) (table item 6, column 2)

Omit “6,450”, substitute “6,500”.

11 Subregulation 2.2(1) (table item 7, column 2)

Omit “166,650”, substitute “167,980”.

12 Subregulation 2.2(1) (table item 8, column 2)

Omit “41,680”, substitute “42,010”.

13 Subregulation 2.2(1) (table item 9, column 2)

Omit “41,830”, substitute “42,160”.

14 Subregulation 2.2(1) (table item 10, column 2)

Omit “238,660”, substitute “240,570”.

15 Subregulation 2.7(2) (heading)

After “listed drugs”, insert “, medicinal preparations”.

16 Paragraph 2.7(2)(b)

After “listed drug”, insert “, medicinal preparation”.

17 Subregulation 3.3(1) (table item 1)

Omit “141,410”, substitute “142,540”.

18 Subregulation 3.3(1) (table item 2)

Omit “111,920”, substitute “112,810”.

19 Subregulation 3.3(1) (table item 3)

Omit “74,090”, substitute “74,680”.

20 Subregulation 3.3(1) (table item 4)

Omit “20,300”, substitute “20,460”.

21 Subregulation 3.3(1) (table item 5)

Omit “13,170”, substitute “12,690”.

22 Paragraph 3.3(3)(a)

Omit “$133,135”, substitute “$134,200”.

23 Paragraph 3.3(3)(b)

Omit “$103,645”, substitute “$104,470”.

24 Paragraph 3.3(3)(c)

Omit “$65,815”, substitute “$66,340”.

25 Subregulation 3A.1(1) (table item 1)

Omit “5,040”, substitute “5,080”.

26 Subregulation 3A.1(1) (table item 2)

Omit “1,970”, substitute “1,980”.

27 Subregulation 3A.1(1) (table item 3)

Omit “10,330”, substitute “10,410”.

28 Subregulation 3A.1(1) (table item 4)

Omit “7,040”, substitute “7,090”.

29 Subregulation 3A.5(2)

Omit “$8,275”, substitute “$8,340”.

30 In the appropriate position in Part 7

Insert:

Division 5—Application provisions relating to amendments commencing on 1 July 2021

7.14 Application provision for the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2021

The amendments of these Regulations made by the National Health (Pharmaceuticals and Vaccines—Cost Recovery) Amendment (Fees) Regulations 2021 apply in relation to applications, notification for which is given on or after 1 July 2021.